Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ICL Group Ltd. Board/Management Information 2016

Mar 14, 2016

6843_ffr_2016-03-14_e8db89a5-7f5e-4d6b-927d-7232d7c2cc18.zip

Board/Management Information

Open in viewer

Opens in your device viewer

6-K 1 dp64198_6k.htm FORM 6-K

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of March, 2016

Commission File Number: 001-13742

ISRAEL CHEMICALS LTD.

(Exact name of registrant as specified in its charter)

Israel Chemicals Ltd.

Millennium Tower

23 Aranha Street

P.O. Box 20245

Tel Aviv, 61202 Israel

(972-3) 684-4400

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F X Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes No X

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes No X

Field: Rule-Page

Field: /Rule-Page Field: Page; Sequence: 1

Field: /Page

ISRAEL CHEMICALS LTD.

  1. End of Tenure of Mr. Eran Sarig, Member of the Board of Directors

Field: Page; Sequence: 2

Field: /Page

Item 1

The Company hereby wishes to report that Mr. Eran Sarig, member of the Company's Board of Directors, will retire from his position, effective as of today, following his retirement as an executive officer in Israel Corporation Ltd.

The Board of Directors wishes to thank Mr. Sarig for his immense contribution to the Company and its achievements.

Field: Page; Sequence: 3

Field: /Page

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

/s/ Kobi Altman
Name: Kobi Altman
Title: Executive Vice President and Chief Financial Officer
/s/ Lisa Haimovitz
Name: Lisa Haimovitz
Title: Senior Vice President, Global General Counsel and Corporate Secretary

Date: March 14, 2016

Field: Page; Sequence: 4; Options: Last

Field: /Page